Aeon Global Health. Revenue Growth Rates (ADAT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Aeon Global Health Corp.  (ADAT)
 

ADAT's Revenue Growth by Quarter and Year

Aeon Global Health.'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADAT Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter June -
3rd Quarter March 2.59
2nd Quarter December 5.53
1st Quarter September 3.36
FY 11.48





ADAT Revenue third quarter 2019 Y/Y Growth Comment
Aeon Global Health Corp. reported drop in Revenue in the third quarter 2019 by -47.09% to $ 2.59 millions, from the same quarter in 2018.
The fall in the third quarter 2019 Aeon Global Health Corp.'s Revenue compares unfavorably to the Company's average Revenue decline of -39.24%.

Looking into third quarter 2019 results within Laboratory Analytical Instruments industry 24 other companies have achieved higher Revenue growth. While Aeon Global Health Corp.' s Revenue meltdown of -47.09% ranks overall at the positon no. 4222 in the third quarter 2019.


ADAT Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter June - -31.64 % - -
3rd Quarter March -47.09 % 234.93 % - -
2nd Quarter December -8.6 % - - -
1st Quarter September -87.85 % - - -
FY   - 508.48 % - -

Financial Statements
Aeon Global Health.'s third quarter 2019 Revenue $ 2.59 millions ADAT's Income Statement
Aeon Global Health.'s third quarter 2018 Revenue $ 4.89 millions Quarterly ADAT's Income Statement


ADAT Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter June - -23.11 % 276.71 % -
3rd Quarter March -53.21 % -19.17 % - -
2nd Quarter December 64.58 % -78.12 % - -
1st Quarter September -10.64 % 402.73 % - -
FY (Year on Year)   - 508.48 % - -


Back to ADAT Growth rate Comparisons >> Back to ADAT Growth rate Comparisons >>


Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #573
Overall #4222

Revenue Y/Y Growth Statistics
High Average Low
13.19 % -39.24 % -86.41 %
(Dec 31 2017)   (Jun 30 2017)
Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #573
Overall #4222
Revenue Y/Y Growth Statistics
High Average Low
13.19 % -39.24 % -86.41 %
(Dec 31 2017)   (Jun 30 2017)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Aeon Global Health.'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
402.4 % 71.82 % -78.12 %
(Jun 30 2016)  


ADAT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2019 Aeon Global Health Corp. disclosed fall in Revenue from the second quarter by -53.21% to $ 2.59 millions, from $ 5.53 millions achived in the previous reporting period.

But that's not important problem, as Aeon Global Health.'s Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Aeon Global Health.'s Revenue growth quarter on quarter, overall rank is 4219.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #600
Overall #4219
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #600
Overall #4219
Revenue Q/Q Growth Statistics
High Average Low
402.4 % 71.82 % -78.12 %
(Jun 30 2016)  


ADAT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2019 Aeon Global Health Corp. disclosed fall in Revenue from the second quarter by -53.21% to $ 2.59 millions, from $ 5.53 millions achived in the previous reporting period.

But that's not important problem, as Aeon Global Health.'s Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Aeon Global Health.'s Revenue growth quarter on quarter, overall rank is 4219.


Aeon Global Health.'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2019)		 12 Months Ending
(Dec 31 2017)		 12 Months Ending
(Sep 30 2017)		 12 Months Ending
(Jun 30 2017)		 12 Months Ending
(Dec 31 2016)
Cumulative Revenue 12 Months Ending $ 15.24 $ 17.53 $ 18.05 $ 42.34 $ 44.09
Y / Y Revenue Growth (TTM) -65.44 % -56.88 % -47.79 % - -
Year on Year Revenue Growth Overall Ranking # 3684 # 3824 # 2529 # 0 # 0
Seqeuential Revenue Change (TTM) -13.11 % -2.87 % -57.36 % -3.96 % 8.42 %
Seq. Revenue Growth (TTM) Overall Ranking # 1777 # 3461 # 3977 # 3420 # 1764


Cumulative Revenue growth Comment
Aeon Global Health.'s cumulative 12 months Revenue continue to drop, but on the faster rate at -65.44% year on year, at Mar 31 2019 compare to the -56.88% decrease at Dec 31 2017. If the Aeon Global Health.'s fiscal year would end at Mar 31 2019, annual Revenue would be $15 millions.

In the Healthcare sector 461 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3684, from total ranking in previous quarter at 3824.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 462
Overall # 3684

Revenue TTM Y/Y Growth Statistics
High Average Low
-47.79 %
 -56.7 %
-65.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 268
S&P 500 # 1777
Cumulative Revenue growth Comment
Aeon Global Health.'s cumulative 12 months Revenue continue to drop, but on the faster rate at -65.44% year on year, at Mar 31 2019 compare to the -56.88% decrease at Dec 31 2017. If the Aeon Global Health.'s fiscal year would end at Mar 31 2019, annual Revenue would be $15 millions.

In the Healthcare sector 461 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3684, from total ranking in previous quarter at 3824.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 462
Overall # 3684

Revenue TTM Y/Y Growth Statistics
High Average Low
-47.79 %
-56.7 %
-65.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 268
S&P 500 # 1777




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ADAT's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2019
Surgery Partners Inc -0.14%$ -0.136 millions
Luminex Corporation-0.31%$ -0.307 millions
Hutchmed china Limited-0.32%$ -0.323 millions
Sonida Senior Living Inc -0.41%$ -0.407 millions
Ironwood Pharmaceuticals inc -0.61%$ -0.615 millions
Becton Dickinson And Company-0.64%$ -0.640 millions
Elanco Animal Health Incorporated-0.69%$ -0.693 millions
Alkermes Plc -0.91%$ -0.910 millions
Dentsply Sirona Inc -1.04%$ -1.035 millions
Abbvie Inc -1.34%$ -1.336 millions
Utah Medical Products Inc-1.42%$ -1.424 millions
American Renal Associates Holdings Inc -1.49%$ -1.495 millions
Phibro Animal Health Corporation-1.52%$ -1.518 millions
Sorrento Therapeutics Inc -1.65%$ -1.649 millions
Catalent Inc -1.66%$ -1.656 millions
Baxter International Inc -1.68%$ -1.681 millions
Allied Healthcare Products inc -1.78%$ -1.781 millions
Jounce Therapeutics inc -1.79%$ -1.786 millions
Envista Holdings Corporation-1.92%$ -1.918 millions
Labcorp Holdings Inc -2.00%$ -2.005 millions
Allergan plc-2.04%$ -2.042 millions
Zimmer Biomet Holdings Inc -2.09%$ -2.087 millions
Arvinas Inc -2.24%$ -2.242 millions
Elite Health Systems Inc -2.77%$ -2.775 millions
Waters Corporation-3.17%$ -3.167 millions
Procyon Corporation-3.27%$ -3.269 millions
Tenet Healthcare Corp-3.28%$ -3.277 millions
Cellular Biomedicine Group Inc -3.33%$ -3.328 millions
Enveric Biosciences Inc -3.41%$ -3.406 millions
Perrigo Company Plc-3.49%$ -3.492 millions


About Aeon Global Health. Revenue Growth Rates (ADAT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.